Please click on the links below to access virtual copies of pertinent meeting documents:

• PROGRAM BOOK
• ABSTRACT BOOK
• PRESENTER DISCLOSURES

Presentation Slides are Available for the Below Sessions:

Regulatory Plenary: GLP-1 Agonists and Neuropsychiatric Disorders

• Rodrigo Mansur, M.D., Ph.D.
• Mahavir Agarwal, MBBS, M.D., Ph.D.
• Nigel Greig, Ph.D.
• Christian Hendershot, Ph.D.

ASCP Lifetime Awardee Talk

• John Kane, M.D.

ASCP Award for Excellence in Clincial Psychopharmacology Education Talk

• Stephen Stahl M.D.

Clinical Updates in Neurotherapeutics

• Noah Philip, M.D

• Joan Camprodon, M.D., M.P.H., Ph.D. 

• Scott Aaronson, M.D., and Charles Conway M.D.

Keynote Plenary

• Joshua Godon, M.D., Ph.D.

Update From Federal and Other Funding Agencies Plenary

• Daniel Falk, Ph.D., National Institute on Alcohol Abuse and Alcoholism (NIAAA)
• Lori Davis, M.D., Veterans Affairs (VA)
• Ivan Montoya, M.D., National Institute on Drug Abuse (NIDA)
• Tracy Wang, M.D., M.H.S,, M.Sc., Patient-centered Outcomes Research Institute (PCORI)
• Fuad Issa, M.D., DLFAPA, Defense Health Agency (DHA)

Please click on the links below to access virtual copies of pertinent meeting documents:

Please click on the links below to access virtual copies of pertinent meeting documents:

• PROGRAM BOOK
• ABSTRACT BOOK
• PRESENTER DISCLOSURES

Presentation Slides are Available for the Below Sessions:

Regulatory Plenary: Pediatric Drug Development in Psychiatry

• Tiffany Farchione, M.D.
• Valentina Mantua, M.D.
• John Alexander, M.D., M.P.H.

ASCP Lifetime Awardee Talk

• Dennis Charney, M.D.

Clinical Updates in Neurotherapeutics

• Gerard Sanacora, M.D.
• Curt LaFrance, M.D.
• Gary Small, M.D.

Keynote Plenary: The Changing Landscape of Clinical Psychiatry: Novel Therapeutics, Methods and Assessments

• Andrew Nierenberg, M.D.
• John Torous, M.D.

Update From Federal and Other Funding Agencies Plenary

• Josh Gordon, M.D., Ph.D., National Institute of Mental Health (NIMH)
• Lori Davis, M.D., Veterans Affairs (VA)
• Ivan Montoya, M.D., National Institute on Drug Abuse (NIDA)
• Elisabeth Houtsmuller, Ph.D., Patient-centered Outcomes Research Institute (PCORI)

"Reassessing Research and Clinical Practice in the Peri-pandemic Era"
Fairmont Scottsdale Princess | Scottsdale, Arizona

Presentation Slides are Available for the Below Sessions:

Lifetime Awardee: Looking Back, Giving Thanks, and Moving Forward: Reflections on 50 Years as Physician/Scientist/Mentor in Geriatric Psychiatry

• Charles F. Reynolds III, M.D.

Clinical Updates in Psychopharmacology Session

• Oliver Freudenreich, M.D.
• Michael Thase, M.D.

Update from Federal and Other Funding Agencies

• Ivan Montoya, M.D., NIDA
• Miriam E. Delphin-Rittmon, Ph.D., SAMHSA
• Jana Drgonova, Ph.D., VA

Regulatory Plenary

• Tiffany Farchione, M.D., FDA
• Georgios Aislaitner, Ph.D., EMA

Live Internet Course

Live Internet Course
Virtual

• Program Book
• Abstract Book – Oral Presentations 
• Abstract Book – Posters
• Disclosures

“Innovations in Personalized Medicine: From Biomarkers to Patient-Centered-Care”
Fairmont Scottsdale Princess, Scottsdale, Arizona

• Program Book
• Abstract Book – Oral Sessions
• Abstract Book – Posters
• Disclosures – Oral

“Treatment of Psychiatric Illness Across the Lifespan”
Loews Miami Beach, Miami Beach, Florida

• Program Book
• Abstract Book – Oral Sessions
• Abstract Book – Posters
• Disclosures – Oral

“Serving the Needs of the Diverse Population”
Loews Miami Beach, Miami Beach, Florida

• Program Book
• Abstract Book – Oral Sessions
• Abstract Book – Posters
• Disclosures – Oral

“Anticipating Future Interventions: Discovering New Targets, Integrative Biomarkers, and Beyond”
Fairmont Scottsdale Princess, Scottsdale, Arizona

• Program Book
• Abstract Book – Oral Sessions
• Abstract Book – Posters
• Disclosures – Oral

“Staging Illness and Treatment:  From Prevention to Recovery”

“New Approaches to Mental Illness in the Era of the National Brain Initiative”

“Identifying Common Targets across Brain Diseases – Implications for Treatment, Development and Delivery”

“Anticipating the Future of Drug Development:  New Targets, Integrative Biomarkers, and Beyond”